Real‐World Evidence on Disparities on the Initiation of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome

Background Management of patients with non–ST‐segment–elevation acute coronary syndrome (NSTE‐ACS) is based on 2020 European Society of Cardiology guidelines, which recommend the preferential use of prasugrel over ticagrelor. Because the selection of the respective P2Y12 inhibitor has to consider la...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Mustafa Yildirim, Matthias Mueller‐Hennessen, Barbara Ruth Milles, Moritz Biener, Hauke Hund, Norbert Frey, Evangelos Giannitsis, Christian Salbach
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2023-08-01
Serie:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Soggetti:	acute coronary syndrome eligibility label use prasugrel ticagrelor
Accesso online:	https://www.ahajournals.org/doi/10.1161/JAHA.123.030879
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!